Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 29, 2025
RichMiner Cloud Mining: Helping Global BTC, XRP, DOGE Cryptocurrency Holders Break New Heights of Wealth
GlobeNewswire
·
May 29, 2025
New York, May 29, 2025 (GLOBE NEWSWIRE) -- The cryptocurrency market will usher in a new round of explosion in 2025, and cloud mining has become a popular choice for investors to obtain passive income. As the industry's leading platform, RichMiner has …
UNICOM Engineering Recognized on CRN’s 2025 Solution Provider 500 List for Excellence in Technology Integration
GlobeNewswire
·
May 29, 2025
CANTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- UNICOM Engineering, a global leader in application platforms, purpose-built systems, and lifecycle support services for software developers, data center infrastructure providers, and OEMs, proudly announces …
Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders
GlobeNewswire
·
May 29, 2025
Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 Company Corrects Record on Common Misconceptions Regarding the Reverse Stock Split Proposal SOUTH SAN …
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, …
Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
GlobeNewswire
·
May 29, 2025
Teva outlines acceleration path into a leading biopharma company Innovative medicines franchise on track to exceed $5 billion by 2030, led by AUSTEDO® (deutetrabenazine), AJOVY® (fremanezumab), UZEDY® (risperidone) and late-stage pipeline with blockbuster …
Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client
GlobeNewswire
·
May 29, 2025
OREM, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in ultra-low temperature freezer technology, today announced the successful completion of a major installation project valued at $550,000. The deployment, which …
KALA BIO to Present at Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
ARLINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today …
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Septerna to Present at Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief Executive …
Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at …
Rezolve Ai to Participate in the 2025 Virtual Tech Conference Presented by Maxim Group LLC
GlobeNewswire
·
May 29, 2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, announced that its Chairman and Chief Executive Officer, Daniel M. Wagner, will participate in a fireside chat in the 2025 Virtual Tech …
ARB IOT Group Limited Announces 1-for-15 Reverse Share Split
GlobeNewswire
·
May 29, 2025
Kuala Lumpur, Malaysia, May 29, 2025 (GLOBE NEWSWIRE) -- ARB IOT Group Limited (Nasdaq: ARBB, the "Company" or “ARB IOT”), today announced that the shareholders and the board of directors of the Company approved a one-for-fifteen reverse share split of the …
Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference, taking place in New York …
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced that …
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its presentation at the …
Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities
GlobeNewswire
·
May 29, 2025
EVANSTON, Ill., May 29, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that highly-regarded industry leaders Robert Rouse and Jason Stephani …
Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders
GlobeNewswire
·
May 29, 2025
DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced …
Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
GlobeNewswire
·
May 29, 2025
CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain The Company’s virology study further confirmed the previous structural and in vitro data that revealed the binding of CC-42344 to PB2 protein of the …
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …